Susan L. Solomon
Susan L. Solomon (born 1951) is an American executive. She is the chief executive officer and co-founder of The New York Stem Cell Foundation (NYSCF). Early life and family. Solomon, the daughter of a pianist and the co-founder of Vanguard Records, grew up in New York City. She graduated from New York University, and she received her JD from Rutgers University School of Law, where she was an editor of the Law Review. She is married to Paul Goldberger, an American architecture critic and educator. They are the parents of three sons and reside in  New York City. Career. Solomon started her career as an attorney at Debevoise & Plimpton and then held executive positions at MacAndrews & Forbes and APAX (formerly MMG Patricof and Co.). She was the founder and President of Sony Worldwide Networks, the Chairman and CEO of Lancit Media Productions, an Emmy award-winning television production company, and then served as the founding CEO of Sotheby's website prior to founding her own strategic management consulting firm Solomon Partners LLC in 2000. Solomon is a founding Board member of the Global Alliance for iPSC Therapies (GAiT) and New Yorkers for the Advancement of  Medical Research (NYAMR). She serves on the Board of the College Diabetes Network and is an emeritus Board member for the Centre for Commercialization of Regenerative Medicine. She also serves on the Board of Directors of the Regional Plan Association of New York, where she is a member of the nominating and governance committee. She previously sat on the strategic planning committee for the inaugural NYSTEM program. Leadership of New York Stem Cell Foundation. In 2005, Solomon co-founded The New York Stem Cell Foundation. Solomon started work as a health-care advocate in 1992 when her son was diagnosed  with type 1 diabetes. As a result of her son's diagnosis and then her mother's death from cancer in 2004, she sought to find a way in which the most advanced medical research could translate more quickly into cures. In conversations with clinicians and scientists, Solomon identified stem cells as the most promising way to address unmet patient needs. NYSCF is now one of the biggest nonprofits dedicated to stem cell research, employing 45 scientists at their Research Institute in Manhattan and funding an additional 75 scientists around the world. Bibliography. Publications Editorials